TUMORS OF THE AMPULLA OF VATER

0
0
1722 days ago, 779 views
PowerPoint PPT Presentation
TUMORS OF THE AMPULLA OF VATER. Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Healing facility. TUMORS OF THE AMPULLA OF VATER. Has the most noteworthy frequency of neoplastic change and threat.

Presentation Transcript

Slide 1

TUMORS OF THE AMPULLA OF VATER Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital

Slide 2

TUMORS OF THE AMPULLA OF VATER Has the most noteworthy occurrence of neoplastic change and danger. Creation of neighborhood cancer-causing agents through the joined cooperations of the parts of bile, pancreatic juice, and duodenal substance. Both benevolent and harmful tumors of the ampulla of Vater happen. The kind tumors incorporate adenomas, gastrointestinal stromal tumors (GISTs) , lipomas, and neuroendocrine tumors. Tumors metastatic from other essential locales have likewise been accounted for

Slide 3

ADENOMA AND ADENOCARCINOMA Most basic threatening tumor of the ampulla of Vater under 10% of all periampullary adenocarcinomas Up to 25% of such tumors that are resectable. Emerge from the mucosal cells of the ampulla of Vater and experience an adenoma–carcinoma movement grouping Benign adenomas may get to be distinctly dysplastic, with ensuing movement to adenocarcinoma. 80% to 90% of adenocarcinomas were encompassed by amiable adenomas In many cases advancement from generous to threatening histology was noted. Hazard variables for ampullary adenocarcinoma incorporate familial adenomatous polyposis (FAP) and Peutz-Jeghers disorder. FAP have higher recurrence of ampullary adenomas, half to 86%

Slide 4

Clinical Features The normal period of patients with ampullary adenoma is the mid-50s For ampullary adenocarcinoma is the mid-60s. Give most ordinarily obstructive jaundice, in 80% Weight misfortune happens in 75% of patients Abdominal agony in half Occult gastrointestinal draining is normal, in 33% of patients Nonspecific side effects, for example, anorexia, dyspepsia, and disquietude Rarely, with pancreatitis auxiliary to pancreatic conduit check With components of sphincter of Oddi brokenness Physical examination incorporate conjunctival or cutaneous icterus and, less regularly, hepatomegaly, an extended irk bladder Positive fecal mysterious blood test result Very once in a while unmistakable silver stools, which result from a mix of the nonattendance of bilirubin and the nearness of blood.

Slide 5

Diagnosis The soonest and most basic research facility variation from the norm is an expansion in the serum antacid phosphatase level Followed by hyperbilirubinemia as the tumor impedes the bile pipe. No tumor markers have been distinguished that are either delicate or particular The principal imaging methodology ought to be ultrasonography or CT to decide the level of biliary deterrent. Double differentiation helical CT is the most useful and financially savvy imaging strategy CT can identify a periampullary mass bigger than 1cm,the level of biliary block, the relationship of the mass with encompassing vascular structures, and the nearness or nonattendance of liver metastases. Endoscopy to envision duodenal mucosal irregularities ERCP is regularly the following method for patients with a presumed ampullary danger EUS has been accounted for to be both dependable and precise in the analysis and organizing

Slide 6

Staging Primary Tumor (T Stage) T1 Tumor constrained to ampulla of Vater T2 Tumor attacks duodenal divider T3 Tumor attacks ≤2 cm into pancreas T4 Tumor attacks >2 cm into pancreas as well as nearby organs Regional Lymph Nodes (N Stage) N0 No local lymph hub metastasis N1 Regional lymph hub metastasis Distant Metastasis (M Stage) M0 No far off metastasis M1 Distant metastasis TNM Stage Grouping Stage I T1 N0 M0 Stage II T2-3 N0 M0 Stage III T1-3 N1 M0 Stage IVA T4 N0-1 M0 Stage IVB T1-4 N0-1 M1

Slide 7

Management Local Excision The principal neighborhood surgical resection of an ampullary tumor was performed by William S. Halsted in 1899. Right now, neighborhood resection of ampullary tumors is held for patients with a generous adenoma or ampullary neuroendocrine tumor and for very chose patients with ampullary adenocarcinoma The choices for nearby treatment are endoscopic catch expulsion, endoscopic removal, and surgical ampullectomy. Pedunculated tubular adenomas littler than 1 cm without extreme dysplasia can be overseen endoscopically, normally with catch extraction, sphincterotomy, and transitory position of a pancreatic channel stent,the danger of deficient resection and repeat is as high as 20% with this strategy. Agent resection For adenomas bigger than 1 cm, agent resection is demonstrated once metastatic infection is prohibited. Postoperative bleakness after neighborhood ampullectomy is low, and death rates lower than 2% have been accounted for.

Slide 8

Review of the writing Beger and associates recognized 62 patients who had experienced ampullectomy for kindhearted neoplasms. After a subsequent period extending from 1 to 156 months, all were free of sickness. Branum and partners announced that of 19 patients with benevolent neoplasms resected with ampullectomy, malady repeated in 5 at a mean of 35 months (run, 8 to 72 months); two of these patients additionally had FAP. Mayo Clinic proposing that such patients might be at hazard for the improvement of adenocarcinoma at the site of repeat. Fifty patients with amiable villous ampullary tumor were treated with neighborhood extraction, and 17 tumors repeated, with actuarial repeat rates of 32% at 5 years and 43% at 10 years. Four of the repeats (24%) were adenocarcinomas

Slide 9

Whipple's method Treatment of decision for patients with ampullary adenocarcinoma Classic pancreaticoduodenectomy, which incorporates a distal gastrectomy, and the pylorus-protecting alteration Local lymph hub resection is satisfactory on the grounds that there are no information to bolster an amplified lymph hub analyzation for ampullary adenocarcinoma. Many focuses revealing agent death rates of under 5% Morbidity rates related with this strategy stay high, from 25% to half In 1997, the gathering at the Johns Hopkins Hospital announced the biggest single-foundation involvement in the administration of adenocarcinoma of the ampulla of Vater One hundred twenty patients with adenocarcinoma were dealt with over a 28-year time frame. Resection was performed in 106 patients (88%), 105 of whom (99%) experienced either a pancreaticoduodenectomy (n = 103) or add up to pancreatectomy (n = 2). The general agent death rate was 3.8%. At least one difficulties happened in 49 patients, for a general dreariness rate of 47%. The most widely recognized confusion was pancreatic fistula, which happened in 23 patients (25%).

Slide 10

Chemotherapy and Radiation Therapy and mitigation There are no information to bolster utilize adjuvant chemoradiation for ampullary adenocarcinoma. Constrained information exhibit that adjuvant chemotherapy with 5-FU, doxorubicin, and mitomycin C postpones tumor repeat in patients with ampullary adenocarcinoma Operative concealment of obstructive jaundice with a Roux-en-Y hepaticojejunostomy is fitting. A gastrojejunostomy additionally ought to be performed in patients with a bargained duodenal lumen to avoid gastric outlet check before death. In the event that the tumor is resolved preoperatively to be unresectable, biliary decompression can be air conditioning complished by methods for endoscopic or percutaneous strategies.

Slide 11

Prognosis Survival in patients with unresectable ampullary adenocarcinoma is 5 to 9 months. The general 5-year survival rate for patients with resected ampullary disease ranges from 25% to 55% The 5-year survival rate is fundamentally superior to that for patients with pancreatic adenocarcinoma In the 1997 Johns Hopkins arrangement, lymph hub status, level of separation, and agent blood misfortune were noteworthy indicators of survival Tumor measurement had no impact on survival, nor did adjuvant treatment In a progression of 101 patients who experienced resection for ampullary adenocarcinoma at Memorial Sloan-Kettering Cancer Center, the 5-year survival rate was 46%, and resection edge status, nodal status, and tumor separation were prescient of survival

SPONSORS

SPONSORS

SPONSORS